Repatha
Product Images NDC 72511-770

Product Visual Gallery

This gallery contains 86 technical images submitted to the FDA as part of the official labeling for Repatha (NDC 72511-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Repatha Amgenusa 01

A line graph showing cumulative incidence (%) over 36 months comparing REPATHA and placebo. The REPATHA group (red dashed line) consistently shows a lower cumulative incidence than the placebo group (blue solid line). The x-axis represents months, and the y-axis represents cumulative incidence percentage. Below the graph is a table indicating the number of patients at risk for both groups at various time points.*

FDA Label Image

Grh0552 Graph Misc Na V1.0 (Repatha Amgenusa 02)

A cumulative incidence line graph comparing REPATHA 140 mg/mL and placebo over 36 months. The x-axis shows time in months, and the y-axis shows cumulative incidence percentage. REPATHA is represented by a red dashed line, consistently showing lower incidence compared to the blue solid line for placebo. The number of patients at risk is indicated below the graph for both groups at multiple time points.*

FDA Label Image

Grh0553 Graph Misc Na V1.0 (Repatha Amgenusa 03)

A comparative bar chart illustrating treatment differences in percent change from baseline LDL-C levels. The chart compares REPATHA 140 mg every 2 weeks and 420 mg once monthly against placebo across several statins and against ezetimibe with atorvastatin at varying dosages. The vertical axis measures percent change in LDL-C, ranging from 0 to -100%. The chart highlights effectiveness of REPATHA administered at different dosing schedules in combination or comparison with statin types and dosages.*

FDA Label Image

Grh0554 Graph Misc Na V1.0 (Repatha Amgenusa 04)

A line graph comparing the percent change from baseline over 52 weeks between REPATHA 420 mg once monthly and placebo once monthly. The y-axis shows percent change from baseline, and the x-axis marks time points at baseline, week 12, 24, 36, and 52. REPATHA shows a marked decrease in percent change compared to placebo. Sample sizes for each group at each time point are indicated below the x-axis.*

FDA Label Image

Grh0434 Graph Misc Na V1.0 (Repatha Amgenusa 05)

A line graph showing percent change from baseline over 12 weeks for four groups: Placebo every 2 weeks, REPATHA 140 mg every 2 weeks, Placebo once monthly, and REPATHA 420 mg once monthly. The chart includes data points at baseline, weeks 2, 8, 10, and 12 with observed sample sizes for each group indicated. REPATHA groups show significant decreases over time compared to placebo groups, which remain near baseline values.*

FDA Label Image

Grh0555 Graph Misc Na V2.0 (Repatha Amgenusa 06)

A line graph depicting percent change from baseline over a 24-week study period, comparing two groups: Placebo QM (N=53) and EvoMab 420 mg QM (N=104). The x-axis represents study weeks (Baseline, Week 12, Week 24), and the y-axis shows percent change from baseline. The Placebo group shows minimal change, while the EvoMab group shows a sharp reduction at Week 12 that remains stable through Week 24. Error bars indicate variability for each time point.*

FDA Label Image

Repatha Amgenusa 07

An instructional diagram showing components of a REPATHA 140 mg/mL cartridge. Labeled parts include the white plunger, cartridge top with a note 'Do not rotate,' cartridge bottom, medicine inside the cartridge, and the cartridge label. The illustration clarifies the cartridge structure for handling or use instructions.*

FDA Label Image

Prefilled Cartridge (Repatha Amgenusa 08)

An instructional diagram of the REPATHA 140 mg/mL injector device showing labeled parts including skin adhesive, status light, start button, cartridge door, medicine window, and pull tabs. It provides a visual guide for identifying each component of the injection device.*

FDA Label Image

On Body Infusor (Repatha Amgenusa 09)

An instructional diagram illustrating the components of a REPATHA injection device. Labeled parts include the needle cover, adhesive paper, needle inside (under cover), battery strip, left pull tab, and right pull tab, showing the device's external layout and openings for use.*

FDA Label Image

Open The On Body Infusor By Swinging The Cartridge Door To The Right. Then, Leave The Door Open. Do Not Close The Cartridge Door Before The Cartridge Is Loaded. (Repatha Amgenusa 10)

An instructional illustration showing the REPATHA on-body infusor system. It labels the clear tray, prefilled cartridge, plastic cover being removed by a hand, and the on-body infusor device itself. This diagram visually explains the components of the REPATHA 140 mg/mL self-administration packaging by Amgen USA Inc.*

FDA Label Image

Inspect The Cartridge. (Repatha Amgenusa 11)

Instructional illustration showing components for the use and disposal of REPATHA 140 mg/mL, including a prefilled injection device, alcohol wipes, tablets or pills, a bandage, and a biohazard sharps container. The image depicts the preparation and safe disposal process associated with the medication.*

FDA Label Image

Clean The Cartridge Bottom. (Repatha Amgenusa 12)

An instructional diagram showing three possible injection sites on a human body for the medication REPATHA 140 mg/mL by Amgen USA Inc.: the upper arm, stomach area (abdomen), and thigh. Each site is shaded and labeled for clear identification.*

FDA Label Image

Loadcartridgestraight (Repatha Amgenusa 13)

An instructional illustration showing a hand lifting the blue protective cap from the top of a REPATHA 140 mg/mL injection device. The device is held in the other hand, highlighting the step of preparing the autoinjector for use.*

FDA Label Image

Press Downfirmly (Repatha Amgenusa 14)

An instructional diagram showing the parts of a REPATHA cartridge labeled with components such as cartridge bottom, medicine, white plunger, cartridge label with lot and expiration date, and cartridge top (marked with a 'Do not rotate' notation). The diagram provides a side view of the cartridge assembly.*

FDA Label Image

Swing The Door To The Left. Then, Squeeze Firmly Until It Snaps Shut. Apply Enough Pressure When Closing The Door And Make Sure There Is A “snap” Before Going To The Next Step. (Repatha Amgenusa 15)

An instructional illustration showing hands preparing a REPATHA 140 mg/mL injection device. The image depicts removing a protective cap from the prefilled syringe cartridge with red arrows indicating the direction to pull for removal.*

FDA Label Image

Peel Away Both Green Pull Tabs To Show The Adhesive. The On Body Infusor Is On When The Blue Status Light Flashes. (Repatha Amgenusa 16)

An instructional illustration showing how to load the cartridge for a REPATHA injection device by Amgen USA Inc. It depicts hands loading the cartridge straight into the device, pressing down firmly, and a clock indicating the cartridge must be injected within 5 minutes after loading.*

FDA Label Image

Stomach Area Placement (Repatha Amgenusa 17)

Instructional illustration showing hands squeezing the top of a Repatha injection device to unlatch or open it, indicated by arrows and the word 'snap'. The image demonstrates how to properly prepare the Repatha 140 mg/mL prefilled injection for use.*

FDA Label Image

Thigh Placement (Repatha Amgenusa 18)

Instructional illustration showing how to peel the skin adhesive of a REPATHA 140 mg/mL injection device using left and right pull tabs. The image also includes icons indicating a flashing light and a beep-beep-beep sound, likely as device operation signals.*

FDA Label Image

When The Blue Light Flashes, The On Body Infusor Is Ready. Keep The Stretch (stomach Area Method Only). Hold The Loaded On Body Infusor With The Blue Light Visible, And Place It On Your Skin. You May Hear Beeps. (Repatha Amgenusa 19)

An instructional illustration showing a hand positioning on the abdominal area, indicating an injection site rectangle on the skin with arrows pointing vertically along the marked area, likely demonstrating the area for subcutaneous injection administration.*

FDA Label Image

What Do I Do If The Loaded On Body Infusor Status Light Continuously Flashes Red And I Hear Beeps (Repatha Amgenusa 20)

An instructional illustration showing the outer thigh as the injection site area for administering a subcutaneous injection. The injection site is indicated by a dotted rectangular outline on the thigh. This type of image is typically used in patient directions for injecting medications such as REPATHA 140 mg/mL.*

FDA Label Image

Flashing Warning Light (Repatha Amgenusa 21)

Instructional illustration showing a person holding the REPATHA 140 mg/mL injection device with both hands, preparing to use it by positioning the device against the skin. The image highlights hand placement and device orientation for administration.*

FDA Label Image

Beep-beep-beep-beep- Beep (Repatha Amgenusa 22)

An instructional illustration showing a REPATHA injection device attached to a person's thigh. The image highlights a flashing blue light indicator and simulates beep-beep-beep sounds, likely representing operation signals of the device during use.*

FDA Label Image

Repatha Amgenusa 23

An instructional illustration showing the use of the REPATHA 140 mg/mL autoinjector by Amgen USA Inc. The image depicts a hand pressing the device's blue activation button, with green flashing light and beep-beep-beep sound indicators to signify activation or operation feedback.*

FDA Label Image

Do Not Re-use (Repatha Amgenusa 24)

An illustration of the REPATHA 140 mg/mL auto-injector device used for subcutaneous injection. The device is shown in a mostly white casing with a dark blue protective cap on the left and a circular window on the right side. A small rectangular button or slider is displayed beneath the window, with a green indicator light above it. The design emphasizes the injection mechanism and user interface of the device.*

FDA Label Image

Serial Number (Repatha Amgenusa 25)

An instructional diagram featuring a green pill-shaped button labeled 'Flashing Light' surrounded by lines indicating flashing. Below it is a red downward arrow containing a clock face showing a countdown of 5 minutes. This likely represents a timing or waiting instruction depicted visually.*

FDA Label Image

Type Bf Applied Part (Repatha Amgenusa 26)

FDA Label Image

Do Not Use If Packaging Is Damaged (Repatha Amgenusa 27)

FDA Label Image

On-body Infusor Containing420 mg/ 3.5 mL (120 mg/ml) (Repatha Amgenusa 28)

An instructional illustration showing a hand removing a cover from a REPATHA autoinjector device, with a focus on the device's indicator light in the 'Light Off' state. A text bubble indicates an audible 'beep-beep-beep' sound from the device.*

FDA Label Image

Sterilized Using Ethylene Oxide (Repatha Amgenusa 29)

An instructional illustration showing a hand disposing a used product container into a red biohazard sharps disposal container. The image emphasizes proper disposal of medical waste to prevent contamination or injury.*

FDA Label Image

Wait At Least 30 Minutes For The Autoinjector To Reach Room Temperature Before Injecting (Repatha Amgenusa 30)

An illustrated diagram depicting a REPATHA injector device with a labeled red flashing warning light. Adjacent to the device is a graphic showing the words "Flashing Warning Light" in a red oval surrounded by red lines, and a black starburst shape containing repeated "beep" sounds, indicating an alert signal.*

FDA Label Image

Inspect The Repatha Sureclick Autoinjector. (Repatha Amgenusa 31)

FDA Label Image

New Autoinjector, Alcohol Wipes, Cotton Ball Or Gauze Pad, Adhesive Bandage, Sharps Disposal Container (see Step 4: Finish) (Repatha Amgenusa 32)

FDA Label Image

Prepare And Clean Your Injection Site. (Repatha Amgenusa 33)

FDA Label Image

Pull The Orange Cap Off Only When You Are Ready To Inject. (Repatha Amgenusa 34)

FDA Label Image

Do Not Leave The Orange Cap Off For More Than Five Minutes. This Can Dry Out The Medicine. (Repatha Amgenusa 35)

REPATHA 140 mg/mL carton label showing a stylized black and white illustration of a vial or bottle with "420 mg" prominently displayed. The label does not show additional text or details about the product other than the large dosage number within the vial graphic. The manufacturer is Amgen USA Inc.*

FDA Label Image

Thigh:stretch Method (Repatha Amgenusa 36)

FDA Label Image

Stomach Or Upper Arm:pinch Method (Repatha Amgenusa 37)

FDA Label Image

Hold The Stretch Or Pinched Skin. With The Orange Cap Off, Place Autoinjector On The Skin At 90 Degrees. Do Not Touch The Gray Start Button Yet. (Repatha Amgenusa 38)

FDA Label Image

Firmly Push Down The Autoinjector Onto The Skin Until It Stops Moving. (Repatha Amgenusa 39)

FDA Label Image

Before Use, Guide To Parts (Repatha Amgenusa 40)

FDA Label Image

Guide To Parts- After Use (Repatha Amgenusa 41)

FDA Label Image

Remove The Repatha Prefilled Syringe Carton From The Refrigerator And Wait 30 Minutes. (Repatha Amgenusa 42)

An instructional diagram of a REPATHA 140 mg/mL injection pen by Amgen USA Inc. It labels key parts of the pen, including a gray start button at the top, an expiration date area, a window showing the medicine inside, and an orange cap with a yellow safety guard covering the needle at the bottom.*

FDA Label Image

1 Rapatha Prefilled Syringe (Repatha Amgenusa 43)

Illustration diagram of a REPATHA 140 mg/mL prefilled pen by Amgen USA Inc., showing labeled parts including expiration date, yellow window indicating injection completion, yellow safety guard covering the needle, and an orange cap that should be removed before use.*

FDA Label Image

Choose Your Injection Site. (Repatha Amgenusa 44)

An illustration of a clock face showing 30 minutes in red, indicating a half-hour time period. The image is a simple graphic with half of the clock shaded and the text '30 minutes' displayed within the shaded area.*

FDA Label Image

Clean Your Injection Site With An Alcohol Wipe. Let Your Skin Dry Before Injecting (Repatha Amgenusa 45)

Illustration showing a REPATHA prefilled syringe with labeled parts: orange cap on, yellow safety guard containing the needle, a window displaying the medicine inside.*

FDA Label Image

Remove Prefilled Syringe From Tray. (Repatha Amgenusa 46)

Illustration showing administration and disposal items for REPATHA 140 mg/mL. It includes a blue prefilled autoinjector pen, medication dosage cards or labels, three white round tablets, a beige adhesive bandage, and a red biohazard sharps container for safe disposal of used injection devices.*

FDA Label Image

Check The Medicine And Syringe. (Repatha Amgenusa 47)

An anatomical illustration highlighting recommended injection sites for REPATHA 140 mg/mL. The diagram shows shaded areas on the upper arm, stomach, and thigh, each labeled accordingly to indicate suitable locations for administering the medication.*

FDA Label Image

Carefully Pull The Gray Needle Cap Straight Out And Away From Your Body. (Repatha Amgenusa 48)

An instructional illustration showing hands removing the orange cap from a REPATHA 140 mg/mL prefilled pen injector, demonstrating the first step in preparing the device for use.*

FDA Label Image

Place The Cap In The Sharpsdisposal Container Right Away. (Repatha Amgenusa 49)

An illustration of a clock face showing a time span of five minutes, highlighted by a shaded red segment representing the duration. The number '5 minutes' is displayed under the clock.*

FDA Label Image

Principal Display Panel1 X 1 mL Prefilled Syringendc 72511-750-01amgen®repatha® (evolocumab)injection140 mg/ml140 mg/mlprefilled Syringefor Subcutaneous Use Onlystore At 2°c To 8°c (36°f To 46°f). Do Not Freeze Or Shake.store In Carton To Protect From Light.(see Side Panel For Additional Storage Information)sterile Solution – No Preservativesingle Userx Onlycaution, See Package Insert For Full Prescribing Information And Instructions For Usethis Product Contains Dry Natural Rubber.keep Out Of The Sight And Reach Of Children (Repatha Amgenusa 50)

An instructional illustration showing a hand with two fingers pinching a fold of skin on the arm. Two black arrows point opposite directions along the skin fold, indicating a technique, likely related to drug administration.*

FDA Label Image

Principal Display Panel1 X 3.5 mL Prefilled Cartridge1 On-body Infusorndc 72511-770-01amgen®repatha® Pushtronex® System(evolocumab)on-body Infusor And Prefilled Cartridge420 mg/3.5 mL420 mg/3.5 mLfor Subcutaneous Use Onlysingle-use Onlysterile Solution – No Preservativestore Refrigerated At 2°c To 8°c (36°f To 46°f). Do Not Freeze Or Shake.store In Carton To Protect From Light.(see Side Panel For Additional Storage Information)keep Out Of The Sight And Reach Of Children.refer To Instructions For Usedo Not Use If Package Is Damagedon-body Infusor Sterilized Using Ethylene Oxidekeep Drydo Not Re-usetype Bf Applied Partrelative Humidityrange Is 15% To 85%rx Only (Repatha Amgenusa 51)

Instructional illustration showing how to pinch the skin on the arm with one hand while holding a syringe with the other hand. The arrows indicate the motion of pinching and insertion for an injection.*

FDA Label Image

Repatha Amgenusa 52

An instructional diagram illustrating the correct subcutaneous injection technique for REPATHA 140 mg/mL. It shows a hand holding the injection device at a 90-degree angle to the skin, with a close-up highlighting the yellow safety guard covering the needle.*

FDA Label Image

Repatha Amgenusa 53

An instructional illustration showing a hand holding a REPATHA 140 mg/mL injection pen, with an arrow indicating the injection direction into the skin, while another hand stabilizes the injection site. The image demonstrates the proper technique for administering a subcutaneous injection using the pen.*

FDA Label Image

Repatha Amgenusa 54

An instructional illustration showing hands administering an injection using a REPATHA 140 mg/mL auto-injector. One hand holds the auto-injector perpendicular to the skin, while the other supports the injection site. An arrow indicates downward motion and a 'click' sound is highlighted to signal proper activation.*

FDA Label Image

Repatha Amgenusa 55

Instructional illustration showing how to use the REPATHA 140 mg/mL autoinjector. It depicts a hand holding the autoinjector upright against the skin, with an arrow indicating downward pressure to activate the injection, accompanied by a 'click' sound to confirm activation.*

FDA Label Image

Repatha Amgenusa 56

An illustration showing a timer set to 15 seconds above a test strip device with a yellow central indicator area, likely representing a timing step in an assay or test procedure.*

FDA Label Image

Repatha Amgenusa 57

FDA Label Image

Repatha Amgenusa 58

An instructional illustration showing a hand disposing of a used REPATHA 140 mg/mL autoinjector pen into a red sharps disposal container marked with a biohazard symbol. The image highlights safe disposal of the injection device after use.*

FDA Label Image

Repatha Amgenusa 59

An instructional diagram of a REPATHA 140 mg/mL autoinjector pen by Amgen USA Inc. The illustration labels parts of the pen, including a gray start button, expiration date area, a transparent window showing the medicine inside, an orange cap, and a yellow safety guard covering the needle.*

FDA Label Image

Repatha Amgenusa 60

An instructional diagram showing recommended injection sites on a human body for a medication. The labeled areas include the upper arm, stomach, and thigh, indicating where injections can be administered.*

FDA Label Image

Repatha Amgenusa 61

An instructional illustration showing how to insert a cartridge into a REPATHA pen injector. One hand holds the pen, while the other hand is placing the cartridge into the pen, indicated by a left-pointing arrow.*

FDA Label Image

Repatha Amgenusa 62

An illustration of a clock face showing a 5-minute interval shaded in red, with the text '5 minutes' inside the clock. This image likely serves as an instructional graphic related to timing or wait period for the use of the REPATHA 140 mg/mL product by Amgen USA Inc.*

FDA Label Image

Repatha Amgenusa 63

An instructional illustration showing a hand performing the 'stretch method' on the skin, indicating a left-right stretch motion with arrows. The text 'Stretch method:' labels the instruction.*

FDA Label Image

Repatha Amgenusa 64

An instructional illustration showing a hand holding a REPATHA 140 mg/mL prefilled syringe with a yellow safety guard indicating the needle is inside. An inset zoom highlights the correct position of the yellow safety guard on the syringe.*

FDA Label Image

Repatha Amgenusa 65

An instructional illustration showing the 'Pinch method' for injection. It depicts a hand pinching the skin with arrows indicating where to pinch and the direction of the pinch. The text 'Pinch method:' is shown to the left of the image.*

FDA Label Image

Repatha Amgenusa 66

An instructional illustration showing the proper technique for administering an injection using a Repatha autoinjector pen. It depicts one hand holding the 140 mg/mL Repatha pen vertically against the skin while the other hand stabilizes the injection site, with an arrow indicating pressing down until a 'click' sound is heard.*

FDA Label Image

Repatha Amgenusa 67

An instructional illustration showing a timer set to 15 seconds next to a vertical device with a yellow indicator bar, likely demonstrating part of the administration or preparation process for a medication injection.*

FDA Label Image

Repatha Amgenusa 68

An instructional illustration showing a hand holding a REPATHA 140 mg/mL pen and pressing it perpendicularly onto the skin to administer the injection, indicated by a downward arrow and a 'click' sound graphic.*

FDA Label Image

Repatha Amgenusa 69

An instructional diagram labeling parts of a syringe containing medicine, including the plunger rod, medicine inside the syringe barrel, and a gray needle cap on the end. This illustration is relevant to the REPATHA 140 mg/mL injectable product by Amgen USA Inc.*

FDA Label Image

Repatha Amgenusa 70

An instructional diagram showing components of a used syringe assembly for REPATHA 140 mg/mL. The image labels the used plunger, used syringe barrel, and used needle, along with a separate gray needle cap removed from the needle.*

FDA Label Image

Repatha Amgenusa 71

An illustration of a clock face showing a 30-minute interval highlighted in red on the right half, with the text '30 minutes' displayed within the red section.*

FDA Label Image

Repatha Amgenusa 72

An instructional illustration showing a prefilled syringe on the left and several medical items on the right, including alcohol pads, cotton balls, an adhesive bandage, and a red biohazard sharps disposal container. The image likely depicts supplies related to administering an injection.*

FDA Label Image

Repatha Amgenusa 73

An instructional diagram showing the recommended injection sites for REPATHA 140 mg/mL. The shaded areas on a human body outline include the upper arms, stomach area, and thighs. Each location is labeled accordingly, indicating where the medication can be administered subcutaneously.*

FDA Label Image

Repatha Amgenusa 74

Instructional illustration showing a person preparing to inject REPATHA by cleaning the abdominal area with an alcohol swab before administration. The image demonstrates proper skin preparation prior to injection.*

FDA Label Image

Repatha Amgenusa 75

An instructional illustration showing four sequential steps for using a syringe. The first step shows a hand holding a syringe in a transparent tray. The second step shows turning the tray over to release the syringe. The third step shows gently pressing the tray to free the syringe. The fourth step shows the syringe held in the palm of a hand, ready for use.*

FDA Label Image

Repatha Amgenusa 76

An instructional diagram of a prefilled syringe labeled REPATHA 140 mg/mL by Amgen USA Inc. The illustration identifies key syringe components: plunger rod, syringe barrel, medicine inside the barrel, syringe label with expiration date, and a gray needle cap on the needle end.*

FDA Label Image

Repatha Amgenusa 77

An instructional illustration showing two hands preparing a syringe. The top hand is pulling upward on a component, while the bottom hand holds the syringe steady, indicating a step in medication preparation or administration.*

FDA Label Image

Repatha Amgenusa 78

An instructional illustration showing a hand dropping a used cartridge into a red biohazard sharps container with a flip-top lid. The container features a biohazard symbol, indicating safe disposal of medical sharps.*

FDA Label Image

Repatha Amgenusa 79

An instructional illustration showing a hand pinching the skin on the arm. Two black arrows indicate the direction of pinching and motion, likely demonstrating how to properly prepare an injection site or administer an injection.*

FDA Label Image

Repatha Amgenusa 80

Instructional illustration showing a hand holding a syringe perpendicular (90 degrees) to the skin surface, indicating the correct injection angle between 45 and 90 degrees for administering a subcutaneous injection.*

FDA Label Image

Repatha Amgenusa 81

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into another person's skin. The syringe is positioned perpendicular to the skin surface with an arrow pointing downward onto the plunger to indicate pressing it.*

FDA Label Image

Repatha Amgenusa 82

An instructional illustration showing a hand pulling an injection syringe out of skin, depicting the step of removing the needle after administering a subcutaneous injection.*

FDA Label Image

Repatha Amgenusa 83

An instructional illustration showing a hand holding a syringe and disposing of it into a red biohazard sharps container with an open lid. The image visually guides the proper disposal of needles or syringes.*

FDA Label Image

Repatha Amgenusa 84

Repatha SureClick (evolocumab) Injection 140 mg/mL prefilled autoinjector carton by Amgen USA Inc. Contains 2 x 1 mL single-dose prefilled autoinjectors. Designed for subcutaneous use only. Label includes storage instructions and cautionary statements.*

FDA Label Image

Repatha Amgenusa 85

Repatha (evolocumab) 140 mg/mL prefilled syringe label from Amgen USA Inc. The label indicates a 1 mL injection for subcutaneous use only. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F) and caution against freezing or shaking. The solution is sterile with no preservative and single-use only.*

FDA Label Image

Repatha Amgenusa 86

The packaging label for REPATHA Pushtronex system (evolocumab) shows a 420 mg/3.5 mL strength in an on-body infusor and prefilled cartridge format. The label includes storage instructions, usage warnings, and manufacturer Amgen USA Inc. The design features text in black and red with a blue Amgen logo and an image of the infusor device.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.